期刊文献+

血小板膜糖蛋白Ⅱb/Ⅲa拮抗剂临床应用的研究进展 被引量:1

下载PDF
导出
摘要 血小板在动脉血栓形成中起着重要的作用.血小板在受到各种刺激后引起活化,产生血小板聚集,导致血栓形成,并常成为致命的因素之一.
出处 《血栓与止血学》 2002年第1期35-38,共4页 Chinese Journal of Thrombosis and Hemostasis
  • 相关文献

参考文献19

  • 1[1]Gershlick AH. Antiplatelet therapy. Hospital Medicine, January,2000, 61: 15-23.
  • 2[2]Steven R, Steinhubl MD. Antiplatelet agents in cardiology: The choice of therapy. Ann Thorac Surg, 2000, 70: 3-8.
  • 3[3]Dorid A, Vorchheimer D, Badinon J, et al. Platelet glycoprotein Ⅱ b/Ⅲ a antagonists in cardiovascular disease. JAMA April, 1999, 281:1407-1414.
  • 4[4]Cook JJ, Bednar B, Lymch JL, et al. Tirofiban(AggrastatR). Cardiovasc Drug Rev, 1999, 17: 199-224.
  • 5[5]The EPILOG investigators. Platelet glycoprotein Ⅱ b/Ⅲ a receptor blockade and low-dose heparin during percutaneous coronary revascularization. N Engl J Med, 1997, 336:1689-1696.
  • 6[6]EPIC investigators. Use of a monoclonal antibady directed against the platelet glycoprotein Ⅱ b/Ⅲ a receptor in high-risk coronary angioplasty. N Engl J Med, 1994, 330:956-961.
  • 7[7]The IMPACT- Ⅱ investigators. Randomised placebo-controlled trial of eptifibation on complications of percutaneous coronary intervention:IMPACT- Ⅱ . Lancet, 1997, 49: 1422-1428.
  • 8[8]The RESTORE investigators. Effects of platelet glycoprotein Ⅱ b/Ⅲ a blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty. Circulation, 1997,96: 1445-1453.
  • 9[9]The ERASER investigators. Acute platelet inhibition with abciximab does not reduce in-stent restenosis. The ERASER Study. Circulation,1999, 100: 799-806.
  • 10[10]The CAPTURE investigators. Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory angina: the CAPTURE Study Lancet, 1997, 349:1429-1435.

同被引文献26

  • 1任霞,王字玲,周虹.血小板膜糖蛋白GPⅡb/Ⅲa的结构及激活机制研究进展[J].中国输血杂志,2005,18(2):159-161. 被引量:6
  • 2马建林,王圣,李新明,苏哲坦,李斌,陈关良,林劲,王卫.冠心病患者D-二聚体、血小板膜糖蛋白测定及临床意义[J].中华心血管病杂志,2005,33(8):724-726. 被引量:21
  • 3奚晓东,赵益明,吴强,蒋惠源,李佩霞,阮长耿.血小板膜糖蛋白酶联免疫测定法的建立及应用[J].中华医学检验杂志,1996,19(4):233-237. 被引量:13
  • 4Wugx,Li FG,Li Px,et al.Detection of plasma alphagranule membrane protein(GMP-140)using radiolabeled monoclonal antibodies in thrombotic disease[J].Haemostasis,1993,23:121-128.
  • 5Coller BS.A new murine monoclonal antibody receptors an activation-dependent change in the conformation and/or microenvironment of the platelet glycoprotein Ⅱ b/m a complex[J].J Clin Inwest,1985,76:101-108.
  • 6Byzova TV,RabbaniR,Dsouza S,et al.Role of integrin alpha(v)beta3 in vascular biology[J].Thromb Haemost,1998,80(5):726-734.
  • 7Coller BS.Blockade of platelet Ⅱ b/Ⅲ a a receptors as an an-tithrombotic strategy[J].Circulation,1995,92:2373-2380.
  • 8White JG,Leistikow EL,Escolar G.Platelet membrane responses to surface and suspension activation[J].Blood Cells,1990,16:43-48.
  • 9Andrews RK,Fox jEB.Platelet receptors in hemostas is[J].Curr opin Biol,1990,2:894.
  • 10Paolo P,Pier G M.The humans platelet membrane glycoprotein Ⅱ b/Ⅲ a a complex:a multifunctional adhesion receptor[J].haematologiea.1992,77:162-168.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部